share_log

HC Wainwright & Co. Maintains Buy on Longboard Pharmaceuticals, Raises Price Target to $60

Benzinga ·  Jan 8 06:29

HC Wainwright & Co. analyst Patrick Trucchio maintains Longboard Pharmaceuticals (NASDAQ:LBPH) with a Buy and raises the price target from $25 to $60.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment